This topic contains a solution. Click here to go to the answer

Author Question: What is the mechanism of action that differentiates opioid agonists from opioid agonist-antagonists? ... (Read 198 times)

lilldybug07

  • Hero Member
  • *****
  • Posts: 546
What is the mechanism of action that differentiates opioid agonists from opioid agonist-antagonists?
 
  1. Opioid agonists block two receptors; opioid agonist-antagonists have no effect on any receptors.
  2. Opioid agonists activate two receptors; opioid agonist-antagonists occupy only one receptor.
  3. Opioid agonists activate one receptor; opioid agonist-antagonists activate both receptors.
  4. Opioid agonists block one receptor; opioid agonist-antagonists block both receptors.

Question 2

The client asks the nurse why he is receiving combination therapy of opioid and nonopioid drugs to manage his pain. The nurse should explain which benefit of combination therapy?
 
  1. Combination therapy prevents addiction to the opioid drug.
  2. Using combination therapy helps to relieve pain synergistically and decreases the risk of side effects.
  3. Combination therapy eliminates the need for follow-up laboratory monitoring.
  4. Combination therapy is standard therapy for all pain management clients.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

k.lashomb

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

Correct Answer: 2
Rationale 1: Opioid agonists do not block receptors. Opioid agonist-antagonists do have effects on the receptors, activating one and blocking or having no effect on the other.
Rationale 2: Opioid agonists activate both mu and kappa receptors, and opioid agonist-antagonists occupy only one receptor and block the other.
Rationale 3: Opioid agonists activate two receptors, and opioid agonist-antagonists activate only one receptor.
Rationale 4: Opioid agonists do not block receptors; opioid agonist-antagonists block only one receptor or have no effect on it.
Global Rationale: Opioid agonists activate both mu and kappa receptors, and opioid agonist-antagonists occupy only one receptor and block the other. Opioid agonists do not block receptors. Opioid agonist-antagonists do have effects on the receptors, activating one and blocking or having no effect on the other. Opioid agonists activate two receptors, and opioid agonist-antagonists activate only one receptor. Opioid agonists do not block receptors; opioid agonist-antagonists block only one receptor or have no effect on it.

Answer to Question 2

Correct Answer: 2
Rationale 1: Although combination therapy can help avoid drug dependency, it does not prevent it.
Rationale 2: Combination therapy does help to relieve pain synergistically, uses a smaller dose of opioid drugs, and decreases related side effects.
Rationale 3: The client will still require regular follow-up monitoring with nonopioid drugs.
Rationale 4: Combination therapy is not standard therapy for all pain management clients.
Global Rationale: Combination therapy does help to relieve pain synergistically, uses a smaller dose of opioid drugs, and decreases related side effects. Although combination therapy can help avoid drug dependency, it does not prevent it. The client will still require regular follow-up monitoring with nonopioid drugs. Combination therapy is not standard therapy for all pain management clients.




lilldybug07

  • Member
  • Posts: 546
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


parker125

  • Member
  • Posts: 332
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

For a complete list of videos, visit our video library